Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Prehydration on Pharmacokinetics of Low-dose Cisplatin
2015-002026-39Phase 4Active
- Sponsor
- Netherlands Cancer Institute
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of cisplatin in cancer (2 arms), sponsored by Netherlands Cancer Institute. Primary endpoint: Pharmacokinetics of cisplatin (Cmax and AUC). Started Jul 2015; status: active.
02
Drugs
cisplatin
03
Conditions
cancer
Beyond the preview
Go deeper on 2015-002026-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002026-39.